vimarsana.com

Page 2 - யூரோப் தகவல்தொடர்புகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Khiron Comments on the Results of Project Twenty21 - UK s Largest Observational Study into Medical Cannabis Products

(1) Khiron is a founding member of Project Twenty 21 and was the first supplier of EU-GMP high-THC dried cannabis flower to the study The findings show that medical Cannabis dramatically improves quality of life for people with life-limiting conditions, including Chronic Pain, Multiple Sclerosis, Tourette s Syndrome and PTSD Legal prescriptions allow patients to access medical cannabis without engaging in criminality and to avoid dependency associated with other medicines commonly prescribed for these debilitating conditions TORONTO, May 11, 2021 /PRNewswire/ Khiron Life Sciences Corp. ( Khiron or the Company ) (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, applauds the publication today in the accredited scientific journal Psychopharmacology of the first findings arising from Project Twenty 21, UK s first and largest national medical cannabis registry that was launched on November

Закавказье опутывается сетью коммуникаций В проектах

Закавказье опутывается сетью коммуникаций В проектах
nv.am - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nv.am Daily Mail and Mail on Sunday newspapers.

Khiron Receives Accreditation for UK Medical Cannabis Education and Partners with UK s Cellen Therapeutics to Improve Clinician Education

Khiron Receives Accreditation for UK Medical Cannabis Education and Partners with UK s Cellen Therapeutics to Improve Clinician Education USA - English Share this article Share this article UK medical professionals may now earn CPD credits through Khiron s medical cannabis education program The Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK, to increase patient access via medical cannabis education As a leading international medical cannabis educator, nearly 1,000 medical professionals in Latin America and the United Kingdom have registered for, or completed, Khiron Academy training TORONTO, April 13, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ( Khiron or the Company ) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce it has received UK Continuing Professional Development ( CPD ) accredita

Khiron Expands Product Offering in UK and Increases Patient Access

Khiron Expands Product Offering in UK and Increases Patient Access Following successful medical cannabis launch in Germany, Khiron 1/14, a high CBD flower is expected to be available in Q2/21 for UK patients Khiron plans to introduce additional cannabis-based medical products with its registered strains, recently exported from Colombia to Europe Supply chain improvements will increase availability of medical cannabis for patients in the United Kingdom TORONTO, April 7, 2021 /PRNewswire/ Khiron Life Sciences Corp. ( Khiron or the Company ) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to provide an operational update with regards to its supply of EU-GMP medical cannabis products to the UK. To help alleviate bottlenecks and stock outs, the Company has established an offshore inventory of dried flower, for the express purpose of serving UK patients.

EDUARD DUMITRAŞCU, PREŞEDINTELE ASOCIAŢIEI ROMÂNE PENTRU SMART CITY: Dezvoltarea comunităţilor regionale nu are legătură nici cu stânga, nici cu dreapta politică

EDUARD DUMITRAŞCU, PREŞEDINTELE ASOCIAŢIEI ROMÂNE PENTRU SMART CITY: Dezvoltarea comunităţilor regionale nu are legătură nici cu stânga, nici cu dreapta politică
bursa.ro - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bursa.ro Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.